Predictive Value and Prognostic Significance of Pan-Immune-Inflammation Value, Systemic Immune-Inflammation Index, and Systemic Inflammatory Response Index in Placenta Accreta Spectrum and Placenta Previa
DOI:
https://doi.org/10.21613/GORM.2025.1587Keywords:
Placenta accreta spectrum, placenta previa, Pan-Immune-Inflammation Value, Systemic Inflammation Response Index, Systemic Immune-Inflammation IndexAbstract
OBJECTIVES: Placenta accreta spectrum (PAS) and placenta previa (PP) are major obstetric complications associated with significant maternal and perinatal morbidity. Inflammatory markers have been increasingly studied for their role in predicting adverse pregnancy outcomes. This study aims to evaluate the predictive and prognostic significance of the Pan-Immune-Inflammation Value (PIV), Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Platelet-to-Lymphocyte Ratio (PLR) in patients diagnosed with PAS and PP.
STUDY DESIGN: A retrospective cohort study was conducted on pregnant women diagnosed with PAS and PP, along with a control group of healthy pregnancies. Preoperative inflammatory markers, including PIV, SII, SIRI, NLR, MLR, and PLR were analyzed. The predictive value of these indices for PAS was assessed using receiver operating characteristic (ROC) curve analysis,
RESULTS: Inflammatory markers were significantly higher in PAS and PP cases (p<0.001). PIV demonstrated the highest predictive value (AUC=0.695, cut-off >692, sensitivity 69.3%, specificity 66.7%). SIRI (AUC=0.671, cut-off >2.76, sensitivity 58.7%, specificity 69.2%), SII (AUC=0.630, cut-off >1012, sensitivity 64%, specificity 57.7%), MLR (AUC=0.673, cut-off >0.3584, sensitivity 68%, specificity 60.3%), and PLR (AUC=0.612, cut-off >144.9, sensitivity 60%, specificity 62.8%) also showed predictive potential.
CONCLUSION: PIV, SII, SIRI, MLR, and PLR are valuable inflammatory markers for predicting PAS and PP, with PIV demonstrating the highest diagnostic accuracy. These indices may serve as useful biomarkers for early risk stratification, potentially contributing to enhanced prenatal management and better-informed perinatal care in high-risk pregnancies.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ruken Dayanan, Ahmet Arif Filiz, Gizem Aktemur, Betul Tokgoz Cakir, Gulsan Karabay, Zeynep Seyhanli, Merve Ayas Ozkan, Dilara Duygulu Bulan, Ali Turhan Caglar

This work is licensed under a Creative Commons Attribution 4.0 International License.
All the articles published in GORM are licensed with "Creative Commons Attribution 4.0 License (CC BY 4.0)". This license entitles all parties to copy, share and redistribute all the articles, data sets, figures and supplementary files published in this journal in data mining, search engines, web sites, blogs and other digital platforms under the condition of providing references.



